These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37670708)

  • 1. Research Progress on hCNT3 Structure/Function and Nucleoside Anticancer Drugs.
    Yue X; Zhang X; Zhang D; Zhang Z; Tang L; Ou Z; Cao Y; Li J; Li Y; Liang L; Liu W; Hu J
    Curr Protein Pept Sci; 2024; 25(2):120-136. PubMed ID: 37670708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inward- and outward-facing homology modeling of human concentrative nucleoside transporter 3 (hCNT3) predicts an elevator-type transport mechanism.
    Yao SYM; Young JD
    Channels (Austin); 2018; 12(1):291-298. PubMed ID: 30096006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted cysteine accessibility method (SCAM) analysis of the transport domain of human concentrative nucleoside transporter 3 (hCNT3) and other family members reveals features of structural and functional importance.
    Mulinta R; Yao SYM; Ng AML; Cass CE; Young JD
    J Biol Chem; 2017 Jun; 292(23):9505-9522. PubMed ID: 28385889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The broadly selective human Na+/nucleoside cotransporter (hCNT3) exhibits novel cation-coupled nucleoside transport characteristics.
    Smith KM; Slugoski MD; Loewen SK; Ng AM; Yao SY; Chen XZ; Karpinski E; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 2005 Jul; 280(27):25436-49. PubMed ID: 15870078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Concentrative Nucleoside Transporter 3 (hCNT3, SLC28A3) Forms a Cyclic Homotrimer.
    Stecula A; Schlessinger A; Giacomini KM; Sali A
    Biochemistry; 2017 Jul; 56(27):3475-3483. PubMed ID: 28661652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric and transport modulation of human concentrative nucleoside transporter 3 at the atomic scale.
    Duan H; Zhou Y; Shi X; Luo Q; Gao J; Liang L; Liu W; Peng L; Deng D; Hu J
    Phys Chem Chem Phys; 2021 Nov; 23(44):25401-25413. PubMed ID: 34751688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological characterization and modeling of the structure activity relationship of the human concentrative nucleoside transporter 3 (hCNT3).
    Hu H; Endres CJ; Chang C; Umapathy NS; Lee EW; Fei YJ; Itagaki S; Swaan PW; Ganapathy V; Unadkat JD
    Mol Pharmacol; 2006 May; 69(5):1542-53. PubMed ID: 16446384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib).
    Ritzel MW; Ng AM; Yao SY; Graham K; Loewen SK; Smith KM; Hyde RJ; Karpinski E; Cass CE; Baldwin SA; Young JD
    Mol Membr Biol; 2001; 18(1):65-72. PubMed ID: 11396613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red fluorescent protein pH biosensor to detect concentrative nucleoside transport.
    Johnson DE; Ai HW; Wong P; Young JD; Campbell RE; Casey JR
    J Biol Chem; 2009 Jul; 284(31):20499-511. PubMed ID: 19494110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human concentrative nucleoside transporter-3 C602R variant shows impaired sorting to lipid rafts and altered specificity for nucleoside-derived drugs.
    Errasti-Murugarren E; Molina-Arcas M; Casado FJ; Pastor-Anglada M
    Mol Pharmacol; 2010 Aug; 78(2):157-65. PubMed ID: 20421346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cation coupling properties of human concentrative nucleoside transporters hCNT1, hCNT2 and hCNT3.
    Smith KM; Slugoski MD; Cass CE; Baldwin SA; Karpinski E; Young JD
    Mol Membr Biol; 2007; 24(1):53-64. PubMed ID: 17453413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors.
    Gupte A; Buolamwini JK
    Bioorg Med Chem Lett; 2009 Feb; 19(3):917-21. PubMed ID: 19097778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and functional characterization of variants in human concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from single nucleotide polymorphisms in coding regions of the hCNT3 gene.
    Damaraju S; Zhang J; Visser F; Tackaberry T; Dufour J; Smith KM; Slugoski M; Ritzel MW; Baldwin SA; Young JD; Cass CE
    Pharmacogenet Genomics; 2005 Mar; 15(3):173-82. PubMed ID: 15861042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vectorial transport of nucleoside analogs from the apical to the basolateral membrane in double-transfected cells expressing the human concentrative nucleoside transporter hCNT3 and the export pump ABCC4.
    Rius M; Keller D; Brom M; Hummel-Eisenbeiss J; Lyko F; Keppler D
    Drug Metab Dispos; 2010 Jul; 38(7):1054-63. PubMed ID: 20360301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells.
    Toan SV; To KK; Leung GP; de Souza MO; Ward JL; Tse CM
    Pflugers Arch; 2003 Nov; 447(2):195-204. PubMed ID: 14504928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib).
    Ritzel MW; Ng AM; Yao SY; Graham K; Loewen SK; Smith KM; Ritzel RG; Mowles DA; Carpenter P; Chen XZ; Karpinski E; Hyde RJ; Baldwin SA; Cass CE; Young JD
    J Biol Chem; 2001 Jan; 276(4):2914-27. PubMed ID: 11032837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition and release of uridine and hCNT3: From multivariate interactions to molecular design.
    Duan H; Hu K; Zheng D; Cheng Y; Zhang Z; Wang Y; Liang L; Hu J; Luo T
    Int J Biol Macromol; 2022 Dec; 223(Pt A):1562-1577. PubMed ID: 36402394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Na+ and H+ on steady-state and presteady-state currents of the human concentrative nucleoside transporter 3 (hCNT3).
    Gorraitz E; Pastor-Anglada M; Lostao MP
    Pflugers Arch; 2010 Aug; 460(3):617-32. PubMed ID: 20495821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of a nucleoside-derived drug transporter variant (hCNT3C602R) showing altered sodium-binding capacity.
    Errasti-Murugarren E; Cano-Soldado P; Pastor-Anglada M; Casado FJ
    Mol Pharmacol; 2008 Feb; 73(2):379-86. PubMed ID: 17993510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conserved glutamate residues Glu-343 and Glu-519 provide mechanistic insights into cation/nucleoside cotransport by human concentrative nucleoside transporter hCNT3.
    Slugoski MD; Smith KM; Ng AML; Yao SYM; Karpinski E; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 2009 Jun; 284(25):17266-17280. PubMed ID: 19380587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.